Literature DB >> 2015670

Fructosamine Test-Plus, a modified fructosamine assay evaluated.

J Baker1, P Metcalf, R Scragg, R Johnson.   

Abstract

We have evaluated Fructosamine Test-Plus, a commercial fructosamine assay based on the reduction of nitro-blue tetrazolium dye in alkaline buffer (Clin Chem 1985;31:1550-4), modified by including a detergent and uricase in the reagent, by changing the concentrations of buffer and dye, and by changing the approach to primary calibration. Specimens were from 2321 participants in a health screening survey in a local workforce. Compared with the original fructosamine method, the Fructosamine Test-Plus method was less affected by protein concentration in the sample and less subject to interference from hyperlipidemia. The changes have also extended the linearity of the assay in the pathological range. However, as a screening method for diabetes mellitus in a population with a disease prevalence of 2.28%, the performance of Fructosamine Test-Plus was similar to the original assay.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015670

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  Effect of donor islet mass on metabolic normalization in streptozotocin-diabetic rats.

Authors:  B Keymeulen; H Teng; M Vetri; F Gorus; P In't Veld; D G Pipeleers
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

2.  Ex vivo instability of glycated albumin: A role for autoxidative glycation.

Authors:  Joshua W Jeffs; Shadi Ferdosi; Hussein N Yassine; Chad R Borges
Journal:  Arch Biochem Biophys       Date:  2017-07-13       Impact factor: 4.013

3.  An evaluation of serum fructosamine as a marker of the duration of hypoproteinaemic conditions in dogs.

Authors:  S I Thoresen; W P Bredal
Journal:  Vet Res Commun       Date:  1998-04       Impact factor: 2.459

4.  Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions.

Authors:  Kerry J Welsh; M Sue Kirkman; David B Sacks
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

5.  Metal complexes as allosteric effectors of human hemoglobin: an NMR study of the interaction of the gadolinium(III) bis(m-boroxyphenylamide)diethylenetriaminepentaacetic acid complex with human oxygenated and deoxygenated hemoglobin.

Authors:  S Aime; G Digilio; M Fasano; S Paoletti; A Arnelli; P Ascenzi
Journal:  Biophys J       Date:  1999-05       Impact factor: 4.033

6.  Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry.

Authors:  C L Vandewalle; T Decraene; F C Schuit; I H De Leeuw; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

7.  Various protein and albumin corrections of the serum fructosamine concentration in the diagnosis of canine diabetes mellitus.

Authors:  A L Jensen
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

8.  Establishing a blood fructosamine reference range for the Brazilian population based on data from ELSA - Brasil.

Authors:  William Pedrosa; Maria de Fátima Haueisen Sander Diniz; Sandhi Maria Barreto; Pedro Guatimosim Vidigal
Journal:  Pract Lab Med       Date:  2018-12-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.